Published 05-28-15
Issued by Novartis
The report offers additional historical data and further consolidation of CR information, as well as an enhanced narrative to provide context for the company's CR reporting.
Novartis has published its Corporate Responsibility (CR) Performance Report for 2014.
In response to feedback received from stakeholders on the company’s 2013 CR Performance Report, the 2014 CR Performance Report offers additional historical data and further consolidation of CR information, as well as an enhanced narrative to provide context for Novartis CR reporting.
Novartis has a strong history of CR activities and has publicly reported on its performance since 2000 through its Annual Report as well as online and printed materials. The 2014 CR Performance Report again uses best-in-class Global Reporting Initiative G4 guidelines.
Novartis CR achievements in 2014 include:
Download the Novartis 2014 CR Performance Report
Send your feedback: corporate.responsibility@novartis.com
Contribute to future Novartis reporting: share your views for an update of the Novartis CR materiality analysis
require_once 'counter/results/hit.php'; //hits counter do not remove
?>
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.